Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening
Biosensors · 04.02.2024 · 14 (2) · 86
DOI: 10.3390/bios14020086 ↗Kurz gefasst
Editorial in der Zeitschrift Biosensors, online erschienen am 04.02.2024. Verfasst von Rohollah Nasiri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Science for Life Laboratory, Division of Nanobiotechnology, Department of Protein Science, KTH Royal Institute of Technology, 17165 Solna, Sweden. Hauptthemen laut MEDLINE: Microfluidics, Tissue Engineering. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The convergence of microfluidics and organ-on-a-chip (OoC) technologies has revolutionized our ability to create advanced in vitro models that recapitulate complex physiological processes [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Science for Life Laboratory, Division of Nanobiotechnology, Department of Protein Science, KTH Royal Institute of Technology, 17165 Solna, Sweden.
- Terasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, USA.
ORCID-Profile: Rohollah Nasiri, Yangzhi Zhu
Zitieren
APA
Nasiri, R., Zhu, Y., & de Barros, N. R. (2024). Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening. Biosensors, 14(2), 86. https://doi.org/10.3390/bios14020086
Vancouver
Nasiri R, Zhu Y, de Barros NR. Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening. Biosensors. 2024;14(2):86. doi:10.3390/bios14020086
BibTeX
@article{Nasiri2024,
author = {Nasiri, Rohollah and Zhu, Yangzhi and de Barros, Natan Roberto},
title = {Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening},
journal = {Biosensors},
year = {2024},
volume = {14},
number = {2},
pages = {86},
doi = {10.3390/bios14020086}
}
EUVIMED